Characterization of magnetic viral complexes for targeted delivery in oncology. - Wikidata - wikimedia - TriplyDB

Characterization of magnetic viral complexes for targeted delivery in oncology.

Characterization of magnetic viral complexes for targeted delivery in oncology.

http://www.wikidata.org/entity/Q35475901

about

Measles to the Rescue: A Review of Oncolytic Measles Virus Targeting of Magnetic Nanoparticle-coated Microbubbles to the Vascular Wall Empowers Site-specific Lentiviral Gene Delivery in vivo Magnetofection Enhances Adenoviral Vector-based Gene Delivery in Skeletal Muscle Cells.Cellular and molecular targets for the immunotherapy of hepatocellular carcinoma.Magnet-Bead Based MicroRNA Delivery System to Modify CD133+ Stem Cells.Efficient and safe gene delivery to human corneal endothelium using magnetic nanoparticles.Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect.Preparation and In Vitro Characterization of Magnetized miR-modified Endothelial Cells.Advanced physical techniques for gene delivery based on membrane perforation

P2860

Q28072097-7981B7EA-53DD-48E3-A10F-19952E2A034F Q28818444-38DDD8B0-3C70-4513-9495-B7DA2D2D43D3 Q36956134-4748BFD5-24A5-4FB8-9BEB-0EFFB5A46B0D Q39358916-45C6090C-88C2-4CC0-AF51-D87B115D5FCF Q41482927-A0CAB2ED-C2A0-4A63-B4B9-92D0A57FA8EC Q42055335-A1D36456-09A2-4508-95C3-DB3C41C8AC79 Q45324119-868EA0E5-5D6A-459A-94C2-322583AEA51F Q45867825-E256E378-983D-4B93-827B-ED9C429C96BD Q57129161-6B9D2DE4-617F-49DB-95A4-F500A6489826

P2860

Characterization of magnetic viral complexes for targeted delivery in oncology.

http://www.wikidata.org/entity/Q35475901

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Characterization of magnetic viral complexes for targeted delivery in oncology.

@ast

Characterization of magnetic viral complexes for targeted delivery in oncology.

@en

type

label

Characterization of magnetic viral complexes for targeted delivery in oncology.

@ast

Characterization of magnetic viral complexes for targeted delivery in oncology.

@en

prefLabel

Characterization of magnetic viral complexes for targeted delivery in oncology.

@ast

Characterization of magnetic viral complexes for targeted delivery in oncology.

@en

P1433

Q35475901-F326EE23-7FA9-4A64-A3CA-FB1B9F65F635

P1476

Q35475901-0B90B20F-053D-4A31-BCF2-CBA015C542EA

P2093

Q35475901-42711BD1-3B77-4FE0-8B62-F015A4283420

Q35475901-5D5F040A-CEAF-47F1-9964-100D9500A773

Q35475901-5F6627BF-CA95-4B2A-8D9E-16866638DCF1

Q35475901-78901B28-C4F9-45A6-9954-8B243F307781

Q35475901-7E6EAB36-450A-4E3C-9D0E-AC4D6F4D13FB

Q35475901-84315A27-0E5E-41C8-96F3-F63708C8AAEE

Q35475901-98F949A7-D4AC-429F-B755-81EF2E74CBE9

Q35475901-BAC90C2F-E8B4-4D9E-AC82-5FD6C595E5A3

P2860

Q35475901-0141D662-88BE-4989-9A1A-447FC5EE9605

Q35475901-0378CB76-D144-4273-A5F2-CA42BB091FA7

Q35475901-04B2C0D5-10C6-4885-8723-BB47B2B593A2

Q35475901-04C5ACE0-2ADE-4945-806A-417EEC51D367

Q35475901-0A40CFCD-0553-41A6-BD44-651D7835FDC6

Q35475901-19ABF9BA-0A52-411D-9FF7-2439DFA45148

Q35475901-1BFCF4CA-A986-48CD-BE14-0164E6EED45D

Q35475901-218BF457-C2AA-450A-95F7-CC136C34D0B1

Q35475901-222595C2-0935-42E0-9FFC-4BAAF04472A6

Q35475901-2C985A39-7771-4BDC-993E-764164D8875D

P304

Q35475901-A3C62AC6-7287-42C8-B168-C015C0D76C17

P31

Q35475901-C8A4B476-9B2F-4365-A9B9-58BD412BF7E4

P356

Q35475901-36A9544C-7935-4BAA-A155-FAC664F6DEB0

P433

Q35475901-102521DE-8604-4F92-A4DA-46FEED5ED14A

P478

Q35475901-3203670D-9F35-40AC-91DB-8DFF2E58B297

P50

Q35475901-5A06D30F-38AE-414B-A647-85E3BE481632

Q35475901-70DD58BD-C131-4E4C-9B99-4BC30FC94FB9

P577

Q35475901-EDD2B305-8951-4ECA-84E0-93B599772B20

P5875

Q35475901-32DEB56B-5A5A-4874-B7C4-5C32E8FC7CAD

P698

Q35475901-CC02B141-A275-42D7-A2DF-D93F513896E3

P932

Q35475901-89AAA8F2-5C70-48E0-82F3-4F47B6D5C532

P356

P1433

P1476

Characterization of magnetic viral complexes for targeted delivery in oncology

@en

P2093

Axel Walch

http://www.w3.org/2001/XMLSchema#string

Ernst J Rummeny

http://www.w3.org/2001/XMLSchema#string

Isabella Almstätter

http://www.w3.org/2001/XMLSchema#string

Marcus Settles

http://www.w3.org/2001/XMLSchema#string

Michaela Aichler

http://www.w3.org/2001/XMLSchema#string

Olga Mykhaylyk

http://www.w3.org/2001/XMLSchema#string

Oliver Ebert

http://www.w3.org/2001/XMLSchema#string

Rickmer Braren

http://www.w3.org/2001/XMLSchema#string

P2860

Magnetically enhanced nucleic acid delivery. Ten years of magnetofection-progress and prospects

Technology insight: in vivo cell tracking by use of MRI.

Relaxation effects of clustered particles.

Solvent relaxation by uniformly magnetized solute spheres. The classical-quantal connection.

MRI contrast agents: current status and future perspectives.

Drug/dye-loaded, multifunctional iron oxide nanoparticles for combined targeted cancer therapy and dual optical/magnetic resonance imaging.

Using polymers to make up magnetic nanoparticles for biomedicine.

Multi-functional magnetic nanoparticles for magnetic resonance imaging and cancer therapy.

Nearly complete regression of tumors via collective behavior of magnetic nanoparticles in hyperthermia

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer.

P304

667-685

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7150/THNO.10438

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Christian Plank

Jennifer Altomonte

P577

2015-03-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275278138

http://www.w3.org/2001/XMLSchema#string

P698

25897333

http://www.w3.org/2001/XMLSchema#string

P932

4402492

http://www.w3.org/2001/XMLSchema#string